Privia Adds Board Expertise and Raises 2026 Revenue Guidance Range
Privia Health Group reported higher Q2 2026 sales of $632.63 million and improved profitability, then lifted its full-year 2026 GAAP revenue outlook to the high end of $2.35 billion to $2.45 billion. The company also appointed physician and healthcare executive Opella Ernest to its board, while investors focus on labor costs, physician shortages, and technology spending.